Results 121 to 130 of about 289,355 (305)

Reliable Task-Constrained Band Selection Method for Hyperspectral Anomaly Detection

open access: yesRemote Sensing
Hyperspectral band selection utilizes a crucial band subset to represent original data. In hyperspectral anomaly detection tailored for specific tasks, detection performance can be enhanced by pre-selecting a subset of bands that are more representative.
Genrui Zhang   +4 more
doaj   +1 more source

Deep Reinforcement Learning for Band Selection in Hyperspectral Image Classification [PDF]

open access: hybrid, 2021
Lichao Mou   +5 more
openalex   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon   +9 more
wiley   +1 more source

Band selection for oxygenation estimation with multispectral/hyperspectral imaging. [PDF]

open access: yesBiomed Opt Express, 2022
Ayala L   +6 more
europepmc   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

open access: yesMolecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee   +8 more
wiley   +1 more source

The 2dF Galaxy Redshift Survey: the bJ-band galaxy luminosity function and survey selection function [PDF]

open access: bronze, 2002
P. Norberg   +28 more
openalex   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

open access: yesMolecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy